Navigation Links
Prenatal exposure to certain pesticides may negatively impact cognitive development in children
Date:4/20/2011

Researchers at Mount Sinai School of Medicine have found that exposure during pregnancy to a family of pesticides called organophosphates may impair child cognitive development. The findings are published online in Environmental Health Perspectives.

From 1998 to 2002, the Mount Sinai Children's Environmental Health Study enrolled a multiethnic population of more than 400 women in their third trimester of pregnancy. The research team collected urine samples during pregnancy and analyzed them for the evidence of metabolized pesticides. The women were then invited to participate in follow-up interviews when their children were ages 12 months, 24 months, and six to nine years.

At 12 and 24 months the children were assessed using the Bayley Scales of Infant development, which is a standardized instrument that measures cognitive and psychomotor development in young children. Between the ages of six and nine years, the researchers administered skill and intelligence tests. The researchers found that exposure to organophosphates negatively impacted perceptual reasoning, a measure of nonverbal problem-solving skills.

"Manufacturers withdrew chlorpyrifos and diazinon, two types of organophosphate pesticides, from the residential market. Despite this, general population exposure to organophosphate pesticides is ongoing," said Stephanie Engel, PhD, who led the study while on faculty at Mount Sinai School of Medicine.

"We have previously reported that prenatal exposure to these pesticides was negatively related to measures of neurobehavioral organization and early markers of central nervous system development in newborns. These new findings show that detrimental effects continue to be seen on cognitive development in early childhood, particularly in subgroups of the population that metabolize these compounds less efficiently," Dr. Engel said.

Dr. Engel's team also examined the influence of variants in a key enzyme that
'/>"/>

Contact: Christie Corbett
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Low sperm count may be associated with prenatal testosterone excess
2. Microarray analysis improves prenatal diagnosis
3. Prenatal meth exposure linked to abnormal brain development
4. How to deliver the news? New advice for doctors diagnosing prenatal Down syndrome
5. Sex-based prenatal brain differences found
6. Good parenting triumphs over prenatal stress
7. Is prenatal screening for rare diseases like spinal muscular atrophy too costly?
8. Prenatal health-care providers inconsistent in weight-gain counseling
9. Rapid prenatal test for alpha-thalassemia
10. Prenatal exposure to BPA and DES may increase breast cancer risk
11. Prenatal exposure to pesticides linked to attention problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 According to ... Market by Assessment Type (Pen & Paper Based, Hosted, ... Corporate Learning, Academic Research), Vertical and Region - Global ... Training Market to grow from USD 2.4 Billion in ... Compound Annual Growth Rate (CAGR) of 25.6% from 2015 ...
(Date:8/26/2015)... , August 26, 2015 ... Four, and Five Factor), Application (Travel & Immigration, Government, ... - Global Forecast to 2020", published by MarketsandMarkets, Multi-Factor ... by 2020, growing at a CAGR of 17.7% between ... and 82 F igures spread through 169 ...
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015 /PRNewswire/ ... announced today it will unveil its "Guardian S" snake ... the National Tactical Officers Association Conference on August 30 ... S is the first-ever commercially available energetically autonomous snake ... and in-field trials and is protected by more than ...
Breaking Biology News(10 mins):Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3
... tempers the killing activity of a specific group of immune ... attack tumor cells and cells infected by viruses. The key ... which has been known for a long time and which ... Dr. Armin Rehm together with immunologist Dr. Uta Hpken of ...
... cause plants to store GM proteins in special ,protein ... increasing the overall protein yield. Researchers writing in the ... the mechanism by which the synthetic biopolymer increases the ... a team of researchers from Agriculture and Agri-Food Canada ...
... Heidelberg, Germany, 6 August 2009 The European ... a new private pension plan for EMBO Fellows. The ... needs of highly mobile scientists. Post-doctoral researchers who ... enrolling in the pension plan from 1 January 2010. ...
Cached Biology News:Estrogen-dependent switch tempers killing activity of immune cells 2EMBO pioneers pension plan for internationally mobile postdoctoral researchers 2EMBO pioneers pension plan for internationally mobile postdoctoral researchers 3
(Date:8/31/2015)... ... 31, 2015 , ... Regulatory agencies have acknowledged impurities especially ... process. Thus, innovator companies must understand what will be needed in the drug ... been hosting multiple educational panels and seminars for experts to share advice concerning ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Food ... food and beverage processors, equipment manufacturers and leaders in the field of academia. ... weighing and formulation for manufacturers of bakery and snacks; beverages; dairy; meat, poultry ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option for ... first commercially available new FDA approved system in the last 14 years, and the ... high Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction rate of 98%, ...
(Date:8/31/2015)... ... August 31, 2015 , ... Proove Biosciences, Inc. is a finalist for ... High Tech Awards. , Now in its 22nd year, this premier awards event celebrates ... across the nation and around the world. The OC Tech Alliance will announce all ...
Breaking Biology Technology:Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3METTLER TOLEDO Hosts Food Safety Educational Center at 2015 PROCESS EXPO 2U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4
... is Superior to Placebo, Similar Efficacy to ... a Day, and Less Daytime Drowsiness, ... (Nasdaq:,CEPH) announced the pooled analysis of two ... (cyclobenzaprine,hydrochloride extended-release capsules), a new once-daily extended-release,skeletal ...
... Quantitative Research ... Worldwide, NEW YORK, ... of those fielded in the US and abroad -- were,conducted online last ... report, released today, indicates that Internet-based market,research -- once the orphan of ...
... Inc. (Nasdaq: ONXX ) today announced that it ... and full year 2007,financial results and provide a business ... Time (2:00 p.m. Pacific Time). Financial results,for the fourth ... released,earlier that day., Interested parties may access a ...
Cached Biology Technology:Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting 2Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting 3Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting 4Technology Transforms Market Research in Pharmaceutical Industry 2Technology Transforms Market Research in Pharmaceutical Industry 3Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast 2